Cetyl-Myristoleate is a naturally ring waxy alcohol (Long Chain Fatty Acid) that was discovered in 1972 by Dr. Harry Dr. Diehl after ten years of intensive research into why Swiss Albino mice are immune to Arthritis, and why arthritis CANNOT be induced in them. At the time of this discovery, Dr. Diehl was working at the National Institute of Health’s research laboratory in Rockville, Maryland. The National Institute of Health would not let him conduct his research at their lab, so Dr. Diehl set up a lab at his home and did the research there. Dr. Diehl had been working for years with a particular strain of white mice (Swiss Albino Mice) that never got arthritis, even when purposely exposed to it. The mice had such a bad reputation among investigators that they carefully avoided using them whenever they wanted to study arthritis.

Dr. Diehl was curious about why this type of mouse was so resistant to arthritis. Consequently, he looked for the chemical in the mouse's body that gave it immunity from the disease. After considerable trial and error, he isolated Cetyl-Myristoleate. When he injected (Please note that when Cetyl-Myristoleate was first discovered and used, it was in the form of a liquid injectable) the substance into mice and rats that were susceptible to arthritis, the compound prevented them from developing this condition. Dr. Diehl continued his research with animal studies. He successfully synthesized the compound CMO from beef fat (tallow), which he found worked as effectively as the compound from the mouse extract.

The secret might have never gotten out if Dr. Diehl himself hadn't developed severe osteoarthritis. Faced with a future of heavy medication, constant pain, and immobility, Dr. Diehl decided to inject himself with his own formula. To his amazement, his pain disappeared almost immediately. The swelling in his joints decreased and his mobility increased dramatically. Without further injections, he continued to improve. In a matter of weeks, he could hardly believe he had ever had arthritis. Furthermore, his arthritis never returned and he had absolutely no side effects.

Dr. Diehl’s physician was so impressed with the surprising results of Dr. Diehls’ self experimentation, that he urged Dr. Diehl to publish his findings. With the doctor's help, Dr. Diehl’s research on Cetyl-Myristoleate was published in the March 1994 issue of the American Journal of Pharmaceutical Sciences; the prestigious peer review journal of the American Pharmaceutical Association and the American Chemical Society. Dr. Diehl applied for and received two U.S. Patents on cetyl myristoleate, the first in 1977 for the treatment of rheumatoid arthritis and then in 1996 for osteoarthritis.

The published article mentioned above, caught the attention of a researcher at the San Diego Clinic Immunological Center in California, Dr. Len Sands. Under Dr. Sand’s direction, physicians and researchers at the institute began treating patients with Cetyl-Myristoleate for a host of autoimmune disorders. They performed clinical studies and they witnessed remarkable results. Please read the clinicals page for more information on these studies and the results they achieved.

An award winning researcher, Dr. Diehl developed over 500 new compounds, several of which were patented by the U.S. Patent Office. Dr. Diehl was recognized in 1958 for developing a new method of preparing 2-deoxy-d-ribose, a sugar found in deoxyribonucleic acid. This sugar is of vital importance to much basic research, and was used by Jonas Salk, M.D., as a culture medium to grow the Salk polio vaccine virus. Dr. Diehl’s process was published in Biochemical Preparations, one of the most authoritative journals on the subject.